News | April 23, 2012

Elekta Announces First Patients Treated with New Multileaf Collimator

St. James's University Hospital Debuts Clinical Use of Elekta's Agility

April 23, 2012 — Patients at St. James’s University Hospital in Leeds, United Kingdom, were the first to benefit from the use of Agility, the latest multileaf collimator (MLC) from Elekta. With twice the number of leaves typical of many standard MLCs, Agility precisely sculpts delivered radiation to the unique contours of the tumor while reducing the risk of exposure to surrounding healthy tissue.

"This truly represents a radical improvement in the way we deliver radiotherapy, combining both speed and precision in tailoring the radiation beams to the exact shape of the patient's tumor," said Vivian Cosgrove, Ph.D., head of radiotherapy physics at St. James's. "Agility enables a faster delivery of advanced radiotherapy treatments. Reduced treatment times will lead to a better experience for the patient and will improve access to the technology for the benefit of more of our patients."

The product of an extensive R&D effort by Elekta to transform cancer care, the leaves of Agility are also capable of traveling at twice the speed of other MLCs commonly used in radiotherapy. This unique capability supports an added capacity for precision beam shaping as well as shorter treatment times, increasing both patient comfort and the clinic's delivery efficiency. Relying on a new design, Agility also has demonstrated extraordinarily low leaf transmission to reduce the patient's non-therapeutic radiation exposure. Agility recently received CE Mark approval.

"Agility's versatility combined with the potential patient benefits have generated much enthusiasm and market demand," says Olof Sanden, executive vice president, Europe and AFLAME, Elekta. "We look forward to many more cancer patients benefiting from this breakthrough technology."

For more information: www.elekta.com/agility

Related Content

Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...